INTRODUCTION
============

It is reported that at least 25% of the world's grains are contaminated with mycotoxins ([@b48-ajas-27-6-907-18]). Aflatoxins (AFs) are known to be very dangerous mycotoxins, with high toxicity to both animals and humans, and are produced mainly by *Aspergillus flavus*, *A. parasiticus*, and some other species of *Aspegillus*, *Penicilium*, and *Rhizopus* ([@b54-ajas-27-6-907-18]; [@b8-ajas-27-6-907-18]). Aflatoxin B~1~ (AFB~1~) is considered the most biologically active form of AFs ([@b23-ajas-27-6-907-18]; [@b26-ajas-27-6-907-18]). The carcinogenicity, teratogenicity, and immunosuppressive effects caused by this toxin are harmful to the health of humans and animals ([@b17-ajas-27-6-907-18]). Animals suffering from aflatoxicosis exhibit various clinical signs, including lethargy, anorexia, and poor performance, as well as damage to tissues ([@b33-ajas-27-6-907-18]; [@b40-ajas-27-6-907-18]). One of the negative impacts of AFB~1~ is cell and tissue injury, which produces free radicals and lipid peroxides ([@b47-ajas-27-6-907-18]). Some reports suggest that AF~S~, possibly associated with the induction of oxidative stress, may be responsible for mediating various toxic effects in tissues ([@b6-ajas-27-6-907-18]; [@b27-ajas-27-6-907-18]; [@b50-ajas-27-6-907-18]). Therefore, some antioxidants might protect against AF-induced tissue damage through modulation of the detoxification and antioxidant systems ([@b14-ajas-27-6-907-18]).

Lipoic acid (LA), a dithiol compound derived from octanoic acid, is a fatty acid that functions as a cofactor in vital energy-producing reactions and thus plays a major role in energy metabolism. As the "universal antioxidant", LA and its reduced form, dihydrolipoate, are metal chelators and scavenge several types of free radicals, and regenerate other antioxidants, such as ascorbate, Vitamin E and glutathione (GSH) ([@b38-ajas-27-6-907-18]; [@b10-ajas-27-6-907-18]). Previous studies from our laboratory have shown that addition of alpha-lipoic acid (α-LA) to diets could enhance the antioxidant capability of broilers ([@b56-ajas-27-6-907-18]; [@b13-ajas-27-6-907-18]) and piglets ([@b5-ajas-27-6-907-18]). Therefore, α-LA has been used in the prevention or treatment of several pathological conditions that are mediated by oxidative stress. [@b41-ajas-27-6-907-18] reported that α-LA is a potential agent to protect against mycotoxins and treat mycotoxicoses such as mushroom poisoning. In addition, [@b22-ajas-27-6-907-18] reported that feeding with 60 mg/kg per body weight (BW) LA might ameliorate the degenerative effects caused by AF (150 and 300 ppb) because of lipid peroxidation. Meanwhile, in our previous study, supplementation of 600 and 900 mg/kg LA (about 52 and 78 mg/kg/BW, respectively) in broiler diet without AF contamination significantly reduced the average daily feed intake and average daily weight gain, but 300 mg/kg LA enhanced antioxidant capability of broilers while having no adverse effect on growth performance ([@b56-ajas-27-6-907-18]). Hence, we speculated that the addition of 300 mg/kg α-LA to the diet could alleviate AFB~1~-induced toxicity by mediating the animal body redox regulation and antioxidant systems, without adverse effect on growth performance.

In keeping with the above views, our objective was to examine the detoxification efficacy of α-LA in ameliorating AFB~1~-induced oxidative damage in broiler chickens.

MATERIALS AND METHODS
=====================

Collection of feed ingredients contaminated with aflatoxin B~1~
---------------------------------------------------------------

A total of 100 feed ingredients were sampled in the scope of the nation, and the contents of mycotoxins including AFB~1~, deoxynivalenol, zearalenone, and ochratoxin A were tested using high performance liquid chromatography (HPLC) according to the method of [@b49-ajas-27-6-907-18]. Two samples of AFB-free peanut meal and peanut meal seriously contaminated with AFB~1~ (330 μg/kg) were selected and incorporated into the basal diet by proportion.

Animals
-------

One-day-old male broiler chickens (Ross 308) were obtained from a commercial hatchery (Chia Tai Co., Ltd, Hebei, China). The brooding temperature was maintained at 35°C and 65% relative humidity (RH) for the first 2 days, and then decreased gradually to 21°C (45% RH) until 28 days and maintained as such until the end of the experiment. The light regime was 23 L:1 D. All chicks were provided *ad libitum* to water and a commercial diet during the rearing period. The animal care protocol in this experiment was according to commercial management practice, and approved by the Animal Welfare Committee of China Agricultural University.

Experimental design
-------------------

After a 10 d adaption period to the diet and surrounding, a total of 160 eleven-day-old birds with similar BW were randomly assigned to 4 groups with 4 replicates pens of 10 birds per pen. Four treatment groups included: fed the basal diet with 21% normal peanut meal (no mycotoxin) (control); administered with 300 mg/kg DL-α-LA (Sigma Chemical, St. Louis, MO, USA) supplementation in the basal diet; fed the diet containing 74 μg/kg AFB~1~ (21% moldy peanut meal naturally contaminated with 330 μg/kg AFB~1~ substituted for normal peanut meal by the same proportion in basal diet); and fed the diet supplemented with 300 mg/kg α-LA and AFB~1~ (determined 74 μg/kg AFB~1~ without other mycotoxins). All essential nutrients in the basal diet ([Table 1](#t1-ajas-27-6-907-18){ref-type="table"}) met or were slightly lower than the nutrient requirements of [@b32-ajas-27-6-907-18]. The composition of diets and the content of AFB~1~ in the diets are shown in [Table 1](#t1-ajas-27-6-907-18){ref-type="table"}. The feeding trial period lasted for 3 weeks.

At the end of the experiment, eight chicks with body weights close to the average were selected from per treatment. After a 12 hours feed withdrawal, blood sample was drawn from a wing vein with a heparinised syringe within 30 s and then transferred to iced tubes. Plasma was obtained from the blood by centrifugation at 3,000 g for 10 min and was stored at −20°C for further biochemical analysis. All chickens were sacrificed for tissue collection after blood sample collection ([@b11-ajas-27-6-907-18]). The liver tissue samples were washed with ice-cold sterilized saline (0.85%), snap frozen in liquid nitrogen and stored at −80°C for further analysis of liver metabolic enzymes and antioxidant indices.

Measurements
------------

### Histological analysis

The degrees of hepatic damage were observed with hematoxylin and eosin staining as described in [@b51-ajas-27-6-907-18]. Sections were examined under an Olympus CX-41 phase contrast microscope (Olympus, Tokyo, Japan).

### Plasma parameters analysis

The concentrations of uric acid (UA), creatinine (CREA), calcium (Ca), total protein (TP) and albumin (ALB) in the blood plasma were measured spectrophotometrically using commercial diagnostic kits (Nanjing Jiancheng Bioengineering Institute, China). Alkaline phosphatase (AKP) activity was quantitatively assayed using an AKP detection kit (Nanjing Jiancheng Bioengineering Institute, China) at 520 nm with a spectrophotometer. The γ-glutamyl transferase (γ-GT) activity was measured using a commercial assay kit (Nanjing Jiancheng Bioengineering Institute, China), it catalyzed the release of 5-amino-2-nitrobenzoate that was measured at 405 nm using a spectrophotometer.

### Assay of metabolic enzyme and antioxidant indices in liver

Liver tissue (1 g) was cut into small pieces and homogenised in ice-cold saline buffer (0.85%, pH = 7.4) (1:9, wt/v) with an Ultra-Turrax (T8, IKA-labortechnik Staufen, Germany) to form homogenates at a concentration of 0.1 g/mL for further analysis. Liver homogenates were centrifuged at 1,000 g for 15 min at 4°C, and the supernatants were collected. The supernatants were used for the assays of glutamic-oxalacetic transaminase (GOT), glutamic-pyruvic transaminase (GPT), total antioxidant capacity (T-AOC), total superoxide dismutase (T-SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GSH-P~X~), malondiadehyde (MDA) and GSH. The assays were determined with the clinical chemistry assay kits (Nanjing Jiancheng Bioengineering Institute, China) according to the manufacturer's recommended procedure.

The activities of GOT and GPT in liver were measured according to the method described by [@b20-ajas-27-6-907-18] using chemical assay kits. In brief, GOT acted on L-aspartate and α-ketoglutaric acid to yield oxaloacetate that subsequently reacted with 2,4-dinitrophenylhy-drazine to generate red-brown colored 2,4- dinitrophenylhy-drazone which was detected at 505 nm using a spectrophotometer; GPT acted on L-aspartate and α-ketoglutaric acid to yield pyruvate that subsequently reacted with 2,4-dinitrophenylhy-drazine to generate red-brown colored 2,4-dinitrophenylhy-drazone which was detected at 505 nm using a spectrophotometer.

MDA concentration was analyzed by the thiobarbituric acid method ([@b36-ajas-27-6-907-18]), reading the absorbance at 532 nm with the spectrometer, result was expressed as nmol/mg protein. GSH content was detected using dithionitrobenzoic acid reagent ([@b19-ajas-27-6-907-18]) and the absorbance at 420 nm was measured, GSH content was expressed as mg GSH per g protein. The T-AOC was determined by the ferric reducing/antioxidant power assay and detected at 520 nm using a spectrophotometer, as described by [@b9-ajas-27-6-907-18]. SOD activity was assayed by the xanthine oxidase method ([@b53-ajas-27-6-907-18]), which monitor the degree of inhibition of nitroblue tetrazolium reduction by O~2~-generated by xanthine and xanthine oxidase, the absorbance was read at 550 nm using a spectrophotometer. CAT activity was determined by measuring the decomposition of H~2~O~2~ at 240 nm. GR activity was measured by the method of [@b12-ajas-27-6-907-18] by measuring the rate of nicotinamide adenine dinucleotide phosphate oxidation as measured decrease in absorbance at 340 nm with a spectrophotometer. GSH-P~X~ activity was detected by determination of the reduction of GSH, the GSH react with 5,5-Dithiobis (2-nitrobenzoic acid), produce yellow colored compounds which were detected at 412 nm using a spectrophotometer ([@b25-ajas-27-6-907-18]).

Liver enzyme activity was expressed as units per mg of protein for liver tissue. The total protein content in liver tissue was determined using a protein assay kit (Nanjing Jiancheng Bioengineering Institute, China), according to the method of [@b28-ajas-27-6-907-18], using bovine serum albumin as a standard. Detailed procedures for the above detections were carried out according to the detection kit instructions.

Statistical analyses
--------------------

All data were subjected to one-way ANOVA using Statistical Analysis Systems (SAS) statistical software package (Version 8e, SAS Institute, Cary, NC, USA). Means were considered significantly different at p\<0.05.

RESULTS
=======

Histopathologic observations
----------------------------

The results of the histopathologic examination of the liver are shown in [Figure 1](#f1-ajas-27-6-907-18){ref-type="fig"}. There was no visible lesion observed in livers of the control and α-LA birds. Livers from birds fed with the diet containing 74 μg/kg of dietary AFB~1~ showed lesions such as mild vacuolar degeneration in hepatocytes, interlobular bile duct hyperplasia and lymphocytes infiltration ([Figure 1C](#f1-ajas-27-6-907-18){ref-type="fig"}). Livers from broilers consuming the AFB~1~ plus α-LA diet showed slight lymphocytes infiltration and slight vacuolar degeneration ([Figure 1D](#f1-ajas-27-6-907-18){ref-type="fig"}). These results suggest a protective effect of α-LA on aflatoxicosis.

Plasma biochemical parameters
-----------------------------

Feeding diet containing 74 μg/kg AFB~1~ to broiler chickens significantly increased the activity of plasma AKP (p\<0.05) and reduced the levels of plasma TP (p\<0.05) and ALB (p\<0.05) compared with normal chickens ([Table 2](#t2-ajas-27-6-907-18){ref-type="table"}). Plasma concentrations of CREA, UA, and Ca and the activity of γ-GT had no statistically significant differences between control and AFB~1~-treated birds (p\>0.05; [Table 2](#t2-ajas-27-6-907-18){ref-type="table"}). Supplementation with 300 mg/kg α-LA in the AFB~1~-contaminated diet significantly improved the plasma values of TP and ALB concentrations and decreased AKP activities compared with chickens fed diet contaminated with AFB~1~ alone ([Table 2](#t2-ajas-27-6-907-18){ref-type="table"}). Birds fed diet containing α-LA without AFB~1~ had significantly increased the TP and ALB levels compared to those in control (p\<0.05; [Table 2](#t2-ajas-27-6-907-18){ref-type="table"}).

Liver metabolic enzyme and antioxidant index
--------------------------------------------

The effects of α-LA on the liver metabolic enzymes and antioxidant index of broiler chickens exposed to AFB~1~ are shown in [Table 3](#t3-ajas-27-6-907-18){ref-type="table"}. As shown in [Table 3](#t3-ajas-27-6-907-18){ref-type="table"}, AFB~1~-treated significantly decreased the liver GOT (p\<0.05) and GPT (p\<0.05) activities compared with the control group. The addition of α-LA (300 mg/kg) into the AFB~1~ diet increased the GOT (p\<0.05) activity compared with chickens fed AFB~1~ alone ([Table 3](#t3-ajas-27-6-907-18){ref-type="table"}). Compared with control chickens, AFB~1~ treatment decreased liver GSH-P~X~ (p\<0.05) activity but had no any significant effects on the T-AOC concentration, T-SOD, CAT, and GR activities (p\>0.05; [Table 3](#t3-ajas-27-6-907-18){ref-type="table"}). The activity of GSH-P~X~ (p\<0.05) in liver of birds fed diet naturally contaminated with AFB~1~ and α-LA (300 mg/kg) was significantly increased compared to that of birds fed diet contaminated with AFB~1~ alone ([Table 3](#t3-ajas-27-6-907-18){ref-type="table"}). The diet containing α-LA significantly increased the T-SOD (p\<0.05), GR (p\<0.05) and GSH-P~X~ (p\<0.05) activities compared to the control group ([Table 3](#t3-ajas-27-6-907-18){ref-type="table"}), which showed that α-LA can significantly improve liver antioxidant status.

Content of malondiadehyde and glutathione in liver
--------------------------------------------------

The results of biochemical analyses for liver MDA and GSH levels are shown in [Figure 2](#f2-ajas-27-6-907-18){ref-type="fig"} and [3](#f3-ajas-27-6-907-18){ref-type="fig"}. Treatment with AFB~1~ caused an increase in MDA content (p\<0.05; [Figure 2](#f2-ajas-27-6-907-18){ref-type="fig"}) while decreasing GSH level (p\<0.05; [Figure 3](#f3-ajas-27-6-907-18){ref-type="fig"}) of liver as compared to the control. Furthermore, simultaneous α-LA (300 mg/kg) treatment to the AFB~1~ diet inhibited the elevation induced by AFB~1~ on the MDA level in liver and suppressed the effect of toxin on the GSH level and made them approach to normal.

DISCUSSION
==========

The presence of AF~S~ in poultry diets is unavoidable because they are produced by ubiquitous fungi. Therefore, AFs pose a substantial risk of economic losses as well as human health problems. This is a particularly major concern in the poultry industry. However, the strategy of using food additives to protect farm animals from toxins may also provide new approaches to protecting human health ([@b52-ajas-27-6-907-18]). α-LA has been used as a nutritional supplement and antioxidant in foods ([@b43-ajas-27-6-907-18]). In a previous study we reported that the chosen supplement amount of α-LA (300 mg/kg) in broilers is similar to human usual dose of α-LA ([@b13-ajas-27-6-907-18]).

The effect of AFB~1~ diets on productivity parameters (BW gain, feed consumption, and feed conversion ratio) and the relative weights of livers did not show significant change compared with control diets (p\>0.05; data not shown). Similar results for chronic exposure to AFB~1~ have been reported previously ([@b35-ajas-27-6-907-18]; [@b30-ajas-27-6-907-18]). It is likely that these parameters (BW gain, feed consumption, feed conversion ratio, or organ development) were not sufficiently sensitive to the chronic effects of lower dose AFB~1~ when the birds were fed diets containing these toxins.

The liver is the main target organ for AFs. AFB~1~ can cause abnormal liver enzyme activity and blood metabolism disorders. Regarding metabolism, a reduction in the contents of plasma TP and ALB, increase in plasma γ-GT and ALP activities, and decrease in liver GOT and GPT activities, have been reported to be indicators of liver toxicity ([@b45-ajas-27-6-907-18]). It has been reported that 50 to 200 μg/kg AFB~1~ in the diet changes the hematological-biochemical profiles in broilers ([@b37-ajas-27-6-907-18]). Here, AFB~1~ induced a significant decrease in levels of plasma TP and ALB and the activities of liver GOT and GPT, which indicate an adverse effect of AFB~1~ on liver function. Histopathological reports confirmed that the AFB~1~ significantly induced hepatic damage, thus supporting the observed biochemical alterations. These results also agree with a previous report of aflatoxicosis in rats ([@b1-ajas-27-6-907-18]) and chickens that received 1 mg/kg AFB~1~ in the basal diet ([@b18-ajas-27-6-907-18]). However, our results differ from others that reported no significant changes in serum biochemistry of broilers exposed to AFB~1~ ranging from 50 to 200 μg/kg ([@b3-ajas-27-6-907-18]; [@b30-ajas-27-6-907-18]). That may be because of the differences that exist in animal breed, age, nutritional or health status, and the time of exposure to AFB~1~. The toxin did not cause any statistically significant change in levels of the plasma UA and CREA (indicators of the toxic effects of AFB~1~ on renal tissue) in AFB~1~-exposed chickens, which may be because the liver tissue is more sensitive to chronic low dose aflatoxins than any other organs. However, supplementation with α-LA almost completely abolished the induction of liver GOT and GPT activities when compared with AFB~1~-treated groups, suggesting that α-LA could effectively suppress AFB~1~-induced liver dysfunction by inhibiting the reduction of liver amino transferases. Here, the decreases in TP and ALB concentrations in the AFB~1~-treated group suggest that the protein synthesis capacity in the liver was suppressed by AFB~1~, similar to our previous report in laying hens ([@b29-ajas-27-6-907-18]). Furthermore, these results also suggest that α-LA can reverse the suppression.

Another threat of AF~S~ on the body is potent hepatotoxicity as a result of antioxidant system damage. As with findings in rats ([@b15-ajas-27-6-907-18]), chickens ([@b37-ajas-27-6-907-18]) and quails ([@b16-ajas-27-6-907-18]), an increase in the MDA content was found in the group of chickens treated with AF~S~ alone. Measurement of MDA is widely used as an indicator of lipid peroxidation, and the increase in lipid peroxidation levels is associated with oxidative stress ([@b37-ajas-27-6-907-18]), which may lead to pathological conditions and diseases ([@b34-ajas-27-6-907-18]). As previously observed by [@b31-ajas-27-6-907-18], an increase in the content of MDA may be secondary to the inhibition of enzymatic antioxidants (e.g., GSH-P~X~ activity) and depletion of non-enzymatic antioxidants (e.g., GSH) in liver in the AFB~1~-treated group compared with the control group chickens. Our study supports the hypothesis that oxidative stress may play a crucial role in AFB~1~-induced liver cell injury ([@b7-ajas-27-6-907-18]; [@b46-ajas-27-6-907-18]).

Using α-LA as a therapeutic agent for some diseases is because of the unique antioxidant properties of the α-LA/dihydrolipoic acid redox couple. These attributes include its reactive oxygen species (ROS) scavenging ability and effects on the tissue content of the reduced forms of other antioxidants, including GSH, one of the most powerful cellular antioxidants ([@b10-ajas-27-6-907-18]). Our previous studies also showed that α-LA could enhance the activities of several enzymatic antioxidants, such as SOD and GSH-P~X~ and increase de novo synthesis of GSH ([@b13-ajas-27-6-907-18]). Several studies have reported that α-LA can protect against hepatic oxidative stress, induced either by certain drugs or under various physiological and pathophysiological conditions ([@b2-ajas-27-6-907-18]; [@b55-ajas-27-6-907-18]). In view of these results, the effect of α-LA on AFB~1~-induced liver oxidative stress was evaluated here. Our results demonstrate that the effects of AFB~1~ on the contents of MDA and GSH and the activities of antioxidant enzymes in the liver were reversed by α-LA. The administration of α-LA to the AFB~1~-contaminated diet significantly increased both the GSH level and the GSH-P~X~ activity compared with the group fed AFB~1~ alone. Moreover, our results showed a decrease in the MDA levels in the liver of birds fed AFB~1~-contaminated diet plus α-LA when compared with those fed a diet containing AFB~1~ alone. The protective effect of α-LA was indicated by the prevention of the lipid peroxide increase and the decreased enzymatic antioxidant activity and non-enzymatic antioxidant levels. Several similar mechanisms have been proposed to explain the protective efficacy of α-LA against the liver oxidative stress induced by certain drugs in rats ([@b39-ajas-27-6-907-18]; [@b4-ajas-27-6-907-18]; [@b2-ajas-27-6-907-18]) and AFB~1~-induced liver damage due to excessive production of lipid peroxidation in chicks ([@b22-ajas-27-6-907-18]).

The GSH redox cycle is an important component of the antioxidant system in cells. The GSH and redox-modulating enzymes in tissues (such as GSH-P~X~ in this study) play an important role in protecting cells from damage by reactive oxygen species. GSH-Px can catalyze the reducing of hydrogen peroxide directly to water and oxygen at the expense of reduced GSH ([@b21-ajas-27-6-907-18]). The depletion of GSH may be due to the decreasing GSH-dependent enzyme GSH-Px, under oxidation stress status, leading to damage of lipids, proteins and DNA by the free radical. α-LA increases GSH levels by improving the cellular availability of cysteine, which is the limiting substrate for GSH biosynthesis ([@b43-ajas-27-6-907-18]). In addition, GSH plays a critical role in protecting tissue damage from AFB~1~ by direct interaction with ROS or as a cofactor of enzymatic detoxification reactions for ROS ([@b24-ajas-27-6-907-18]). Thus, the increase of MDA level, the depletion of intracellular GSH and the induction of GSH-P~X~ activity were found in the AFB~1~-treated group. These results indicate that the presence of increased levels of reactive oxygen species, hydrogen peroxide and lipid hydroperoxide may exceed the cellular defense capacity, thus resulting in oxidative stress. The dysregulated antioxidant balance in the liver of the AFB~1~-treated chickens may also correlate with severe liver function damage as shown by the reduction of liver GOT and GPT activities. However, these negative effects induced by AFB~1~ in the liver were inhibited by supplementation with α-LA, indicating that α-LA enhanced free radical scavenging and antioxidant status, further ameliorated the AFB~1~-induced oxidative stress. Furthermore, [@b42-ajas-27-6-907-18] also reported that α-LA can prevent oxidative stress by increasing free radical scavenging capacity and inhibiting lipid peroxidation and GSH depletion, and by inducing of antioxidant enzyme activity. Together, the results described above suggest that α-LA supplementation effectively improves defense against AFB~1~-induced oxidative stress.

In summary, our experiment clearly indicates that α-LA has the ability to ameliorate AFB~1~-induced liver oxidative damage and may contribute to the inhibition of oxidation stress and maintenance of intracellular antioxidants status.
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![Photomicrographs (optical microscopy) of hematoxylin and eosin-stained broiler liver sections from different treatments. Normal liver architecture in control (A) and alpha-lipoic acid (ALA) (B) treated animals. Obvious liver lesion such as interlobular bile duct proliferation (blue arrow), lymphocyte infiltration (black arrow) and mild vacuolar degeneration in hepatocytes (red arrow) were observed in aflatoxin B1 (AFB~1~)-treated chick (C). Slight lymphocytes infiltration (arrow) and slight vacuolar degeneration were visible in a chick given AFB~1~ plus ALA (D). Scale bar = 50 μm. Color version available in the online PDF. Original magnification: ×200.](ajas-27-6-907-18f1){#f1-ajas-27-6-907-18}

![Effect of alpha-lipoic acid (ALA) on the content of malondiadehyde (MDA) in the liver of broilers fed a diet containing aflatoxin B~1~ (AFB~1~) (n = 8). \* p\<0.05 compared to untreated control group. \*\* p\<0.05 compared to AFB~1~-treated group.](ajas-27-6-907-18f2){#f2-ajas-27-6-907-18}

![Effect of alpha-lipoic acid (ALA) on the content of glutathione (GSH) in the liver of broilers fed a diet containing aflatoxin B~1~ (AFB~1~) (n = 8). \* p\<0.05 compared to untreated control group. \*\* p\<0.05 compared to AFB~1~-treated group.](ajas-27-6-907-18f3){#f3-ajas-27-6-907-18}

###### 

Composition of the diets during the experiment

  Item                                                              Composition
  ----------------------------------------------------------------- ------------------------------------------------------------------
  Ingredient (%)                                                    
   Corn                                                             57.7
   Expanded soybean                                                 6.00
   Soybean meal                                                     8.20
   Peanut meal[1](#tfn2-ajas-27-6-907-18){ref-type="table-fn"}      21.0
   Limestone                                                        1.30
   Dicalcium phosphate                                              1.80
   Salt                                                             0.30
   Corn oil                                                         2.00
   Lysine (98.5%)                                                   0.47
   DL-methionine                                                    0.36
   Threonine                                                        0.19
   Salinomycin                                                      0.07
   Choline chloride                                                 0.10
   15% chlortetracycline                                            0.07
   Mordenzeo                                                        0.11
   Vitamin premix[2](#tfn3-ajas-27-6-907-18){ref-type="table-fn"}   0.03
   Mineral premix[3](#tfn4-ajas-27-6-907-18){ref-type="table-fn"}   0.30
   Total                                                            100
  Nutrition component                                               
   ME (MJ/kg)                                                       12.55
   CP (%)                                                           21.5
   Calcium (%)                                                      0.99
   Total phosphorus (%)                                             0.65
   Nonphytate phosphorus (%)                                        0.43
   Methionine (%)                                                   0.62
   Methionine+cystine (%)                                           0.91
   Lysine (%)                                                       1.17
   Tryptophan (%)                                                   0.21
   Threonine (%)                                                    0.82
   AFB~1~(μg/kg)                                                    0/0/74.36/73.44 [4](#tfn5-ajas-27-6-907-18){ref-type="table-fn"}

ME, metabolizable energy; CP, crude protein; AFB~1~, aflatoxin B~1~.

AFB-free peanut meal was replaced by AFB-contaminated peanut meal according to the same proportion in trail diets.

Provided per kilogram of diet: vitamin A, 15,000 IU; cholecalciferol, 3000 IU; vitamin E, 20 IU; vitamin K~3~, 2.18 mg; thiamine, 2.15 mg; riboflavin, 8.00 mg; pyridoxine, 4.40 mg; vitamin B~12~, 0.02 mg; Calcium pantothenate, 25.60 mg; nicotinic acid, 65.80 mg; folic acid, 0.96 mg; biotin, 0.20 mg.

Provided per kilogram of diet: Fe, 109.58 mg; Cu, 8.14 mg; Zn, 78.04 mg; Mn, 105.00 mg; I, 0.34 mg; Se, 0.14 mg; choline chloride, 1,500 mg.

Four analysis values of AFB~1~ came from Control, alpha-lipoic acid (ALA), AFB~1~ and ALA+AFB~1~ groups, respectively.

###### 

Effect of alpha-lipoic acid (ALA) on plasma chemistry in broilers fed a diet containing aflatoxin B~1~ (AFB~1~) (n = 8)

  Index           Control   ALA                                                      AFB~1~                                                   ALA+AFB~1~                                                 SEM
  --------------- --------- -------------------------------------------------------- -------------------------------------------------------- ---------------------------------------------------------- ------
  TP (g/L)        19.02     26.11[\*](#tfn7-ajas-27-6-907-18){ref-type="table-fn"}   15.64[\*](#tfn7-ajas-27-6-907-18){ref-type="table-fn"}   20.11[\*\*](#tfn8-ajas-27-6-907-18){ref-type="table-fn"}   0.82
  ALB (g/L)       17.02     19.88[\*](#tfn7-ajas-27-6-907-18){ref-type="table-fn"}   13.06[\*](#tfn7-ajas-27-6-907-18){ref-type="table-fn"}   16.65[\*\*](#tfn8-ajas-27-6-907-18){ref-type="table-fn"}   0.61
  AKP (IU/L)      16.19     12.77                                                    24.98[\*](#tfn7-ajas-27-6-907-18){ref-type="table-fn"}   15.70[\*\*](#tfn8-ajas-27-6-907-18){ref-type="table-fn"}   1.13
  γ-GT (U/L)      19.88     18.88                                                    19.75                                                    19.00                                                      0.49
  UA (μmol/L)     149.18    123.58                                                   166.82                                                   161.88                                                     6.27
  CREA (μmol/L)   24.25     21.88                                                    22.50                                                    23.38                                                      0.33
  Ca (mmol/L)     2.67      2.60                                                     2.61                                                     2.51                                                       0.02

SEM, standard error of the mean; TP, total protein; ALB, albumin; AKP, alkaline phosphatase; γ-GT, γ-glutamyl transferase; UA, uric acid; CREA, creatinine; Ca, calcium.

p\<0.05 compared to untreated control group.

p\<0.05 compared to AFB~1~-treated group.

###### 

Effect of Alpha-lipoic acid (ALA) on liver metabolic enzyme and antioxidant index in broilers fed a diet containing aflatoxin B~1~ (AFB~1~) (n = 8)

  Index                     Control   ALA                                                        AFB~1~                                                    ALA+AFB~1~                                                                                                      SEM
  ------------------------- --------- ---------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------------------------------------------------------------- -------
  GOT (U/mg protein)        55.86     79.53[\*](#tfn10-ajas-27-6-907-18){ref-type="table-fn"}    48.52[\*](#tfn10-ajas-27-6-907-18){ref-type="table-fn"}   57.13[\*\*](#tfn11-ajas-27-6-907-18){ref-type="table-fn"}                                                       2.24
  GPT (U/mg protein)        10.27     11.05[\*](#tfn10-ajas-27-6-907-18){ref-type="table-fn"}    8.72[\*](#tfn10-ajas-27-6-907-18){ref-type="table-fn"}    10.00                                                                                                           0.29
  T-AOC (U/mg protein)      1.55      1.86                                                       1.34                                                      1.73[\*\*](#tfn11-ajas-27-6-907-18){ref-type="table-fn"}                                                        0.06
  T-SOD (U/mg protein)      183.36    210.36[\*](#tfn10-ajas-27-6-907-18){ref-type="table-fn"}   174.63                                                    200.35[\*](#tfn10-ajas-27-6-907-18){ref-type="table-fn"},[\*\*](#tfn11-ajas-27-6-907-18){ref-type="table-fn"}   4.16
  CAT (U/g protein)         243.64    257.86                                                     242.21                                                    241.54                                                                                                          10.16
  GR (U/g protein)          3.30      4.50[\*](#tfn10-ajas-27-6-907-18){ref-type="table-fn"}     2.56                                                      3.09                                                                                                            0.21
  GSH-P~X~ (U/mg protein)   21.44     26.21[\*](#tfn10-ajas-27-6-907-18){ref-type="table-fn"}    14.99[\*](#tfn10-ajas-27-6-907-18){ref-type="table-fn"}   20.92[\*\*](#tfn11-ajas-27-6-907-18){ref-type="table-fn"}                                                       0.86

SEM, standard error of the mean; GOT, glutamic-oxalacetic transaminase; GPT, glutamic-pyruvic transaminase; T-AOC, total antioxidant capacity; T-SOD, total superoxide dismutase; CAT, catalase; GR, glutathione reductase; GSH-P~X~, glutathione peroxidase.

p\<0.05 compared to untreated control group.

p\<0.05 compared to AFB~1~-treated group.

[^1]: State Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China

[^2]: Y. Li and Q. G. Ma are the co-first authors.
